Imago BioSciences, Inc.
IMGODelisted Jan 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623715
Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 106
- Q4 2022, +41 vs. previous quarter
- 13F value
- $1.05B
- Reported value at the end of Q4 2022
- Superinvestors holding
- 0
- At the end of Q4 2022
Superinvestors holding IMGO, Q4 2022
No superinvestor reported holding IMGO at the end of Q4 2022.
Latest insider trades
Open-market purchases and sales by Imago BioSciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2022 (view filing) | Dec 27 | 2 days | Eichorn Laura G.Chief Financial Officer | SSale | −3.10K | $35.93 | −$111.4K | −1.5%207.7K after | |
| Dec 29, 2022 (view filing) | Dec 27 | 2 days | Arenberg MichaelSee Remarks | SSale | −70.5K | $35.93 | −$2.53M | −58.8%49.4K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Tapper Amy E.See Remarks | SSale | −100.3K | $35.78 | −$3.59M | −45.7%119.0K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Arenberg MichaelSee Remarks | SSale | −47.8K | $35.78 | −$1.71M | −65.7%24.9K after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Peppe JenniferSee Remarks | SSale | −119.4K | $35.80 | −$4.28M | −44.5%148.8K after | Duplicate filing |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Peppe JenniferSee Remarks | SSale | −119.4K | $35.80 | −$4.28M | −44.5%148.8K after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Eichorn Laura G.Chief Financial Officer | SSale | −126.7K | $35.79 | −$4.54M | −37.9%207.7K after | |
| Dec 19, 2022 (view filing) | Dec 15-16 | 4 days | Rienhoff Hugh JRChief Executive Officer | SSale | −473.1K | $35.79 | −$16.9M | −49.1%489.5K after | 2 lots |
| Nov 4, 2022 (view filing) | Nov 2 | 2 days | Tapper Amy E.See Remarks | SSale | −750 | $17.90 | −$13.4K | −0.6%119.0K after | |
| Nov 4, 2022 (view filing) | Nov 2 | 2 days | Eichorn Laura G.Chief Financial Officer | SSale | −553 | $18.00 | −$9.95K | −0.3%207.7K after |
Top 10 13F holders, Q4 2022
The largest institutional positions in Imago BioSciences, Inc. at the end of Q4 2022; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 4,480,897 | $161.1M | 0.01% | +218,820+5.1% | Added |
| Frazier Life Sciences Management, L.P. | 3,987,207 | $143.3M | 8.91% | +1,015,933+34.2% | Added |
| Omega Fund Management, LLC | 3,018,737 | $108.5M | 36.57% | 00.0% | Unchanged |
| Blackstone Group Inc. | 2,375,037 | $85.4M | 0.33% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,265,741 | $45.5M | 0.00% | +29,469+2.4% | Added |
| Versor Investments LP | 1,005,494 | $36.1M | 3.11% | +1,005,494 | New |
| TIG Advisors, LLC | 990,664 | $35.6M | 2.43% | +990,664 | New |
| Alpine Associates Management Inc. | 975,900 | $35.1M | 1.60% | +975,900 | New |
| Magnetar Financial LLC | 728,083 | $26.2M | 0.44% | +728,083 | New |
| Woodline Partners LP | 578,829 | $20.8M | 0.29% | +121,693+26.6% | Added |